| 摘要 |
The present invention provides methods and materials for diagnosing cancer in an individual using a tissue, blood or urine sample from the patient. Specifically, the disclosed method comprises determining the level of one or more metabolite selected from the group consisting of creatine riboside, metabolite 561+, Cortisol sulfate and N-acetylneuraminic acid. The present invention also provides a method for determining the prognosis of a cancer patient by determining the level of one or more metabolite selected from the group consisting of creatine riboside, metabolite 561+, Cortisol sulfate and N-acetylneuraminic acid. Also provided are kits for detecting cancer or determining the prognosis of a cancer patient. |
| 申请人 |
THE UNITETD STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
发明人 |
HAZNADAR, MAJDA;MATHE, EWY;HARRIS, CURTIS, CRAIG;PATTERSON, ANDREW, D.;MANN, SOUMEN;GONZALEZ, FRANK;KRAUSZ, KRISTOPHER |
